De Moraes CG - Search Results

1

Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence.

Wang M, Tichelaar J, Pasquale LR, Shen LQ, Boland MV, Wellik SR, De Moraes CG, Myers JS, Ramulu P, Kwon M, Saeedi OJ, Wang H, Baniasadi N, Li D, Bex PJ, Elze T. Wang M, et al. Among authors: de moraes cg. JAMA Ophthalmol. 2020 Feb 1;138(2):190-198. doi: 10.1001/jamaophthalmol.2019.5413. JAMA Ophthalmol. 2020. PMID: 31895454 Free PMC article.

2

A comparison of functional and structural measures for identifying progression of glaucoma.

Xin D, Greenstein VC, Ritch R, Liebmann JM, De Moraes CG, Hood DC. Xin D, et al. Among authors: de moraes cg. Invest Ophthalmol Vis Sci. 2011 Jan 25;52(1):519-26. doi: 10.1167/iovs.10-5174. Print 2011 Jan. Invest Ophthalmol Vis Sci. 2011. PMID: 20847115 Free PMC article.

3

Effect of successful and partly successful filtering surgery on the velocity of glaucomatous visual field progression.

Folgar FA, De Moraes CG, Teng CC, Tello C, Ritch R, Liebmann JM. Folgar FA, et al. Among authors: de moraes cg. J Glaucoma. 2012 Dec;21(9):615-8. doi: 10.1097/IJG.0b013e31821db409. J Glaucoma. 2012. PMID: 21623221

4

Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics.

Park SC, De Moraes CG, Teng CC, Tello C, Liebmann JM, Ritch R. Park SC, et al. Among authors: de moraes cg. Ophthalmology. 2011 Sep;118(9):1782-9. doi: 10.1016/j.ophtha.2011.02.013. Epub 2011 Jun 12. Ophthalmology. 2011. PMID: 21665283

5

The region of largest β-zone parapapillary atrophy area predicts the location of most rapid visual field progression.

Teng CC, De Moraes CG, Prata TS, Liebmann CA, Tello C, Ritch R, Liebmann JM. Teng CC, et al. Among authors: de moraes cg. Ophthalmology. 2011 Dec;118(12):2409-13. doi: 10.1016/j.ophtha.2011.06.014. Epub 2011 Sep 1. Ophthalmology. 2011. PMID: 21885127

6

Corneal hysteresis and Beta-zone parapapillary atrophy.

Hayes DD, Teng CC, de Moraes CG, Tello C, Liebmann JM, Ritch R. Hayes DD, et al. Among authors: de moraes cg. Am J Ophthalmol. 2012 Feb;153(2):358-362.e1. doi: 10.1016/j.ajo.2011.06.025. Epub 2011 Sep 13. Am J Ophthalmol. 2012. PMID: 21920490

7

Visual field progression outcomes in glaucoma subtypes.

De Moraes CG, Liebmann JM, Liebmann CA, Susanna R Jr, Tello C, Ritch R. De Moraes CG, et al. Acta Ophthalmol. 2013 May;91(3):288-93. doi: 10.1111/j.1755-3768.2011.02260.x. Epub 2011 Oct 5. Acta Ophthalmol. 2013. PMID: 21974913 Free article.

8

Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.

De Moraes CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group. De Moraes CG, et al. Invest Ophthalmol Vis Sci. 2012 Apr 2;53(4):1704-9. doi: 10.1167/iovs.11-8186. Invest Ophthalmol Vis Sci. 2012. PMID: 22395889 Free PMC article. Clinical Trial.

9

A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.

De Moraes CG, Sehi M, Greenfield DS, Chung YS, Ritch R, Liebmann JM. De Moraes CG, et al. Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2702-7. doi: 10.1167/iovs.11-7900. Invest Ophthalmol Vis Sci. 2012. PMID: 22447872 Free PMC article.

10

Risk factors for visual field progression in the low-pressure glaucoma treatment study.

De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T; Low-pressure Glaucoma Treatment Study Group. De Moraes CG, et al. Am J Ophthalmol. 2012 Oct;154(4):702-11. doi: 10.1016/j.ajo.2012.04.015. Epub 2012 Jul 25. Am J Ophthalmol. 2012. PMID: 22835512 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page